NYSE:EWMedical Equipment
Edwards Lifesciences (EW) Stock Could Be 11% Undervalued on Its TAVR and EVOQUE Story
Edwards Lifesciences (EW) stock has drawn fresh attention as investors review its recent performance and financial profile, including a last close of $86.28 and full year revenue of $6,303.5 million.
See our latest analysis for Edwards Lifesciences.
Over the past year, Edwards Lifesciences has paired a 15.32% total shareholder return with steady short term momentum, including a 6.02% 1 month share price return and a 2.39% 3 month share price return. This performance suggests gradually...